Mexico as a fertility destination in 2026: the numbers and the legal landscape

If you are weighing whether to travel to Mexico for IVF, the first question is usually emotional: is this a serious place to do something this important? The second is practical: what does the law actually say? Both deserve answers grounded in data rather than brochures. Here is where things stand in 2026.

A medical tourism industry measured in millions

Mexico is not a niche destination that happens to have a few fertility clinics. According to Mexico’s Secretaría de Turismo, the country ranks second in the world for medical tourism, behind only Thailand, receiving up to 3 million medical-tourism visits a year. The Consejo Mexicano para el Turismo Médico (CMTM) counted roughly 1.2 million international patients in 2024, generating about US$5.2 billion, and projects the sector will keep growing at 13.3% a year through 2030.

Who are these patients? The Medical Tourism Association reports that eight in ten come from the United States, drawn by savings that typically run 40–80% compared with U.S. prices. Dentistry, cosmetic surgery and bariatric procedures still dominate the volume, which is worth being honest about: fertility is a smaller slice. But it is a slice that sits on top of a very large, mature infrastructure — international airports, hospital networks, bilingual staff, and decades of experience receiving patients from abroad.

One of Latin America’s three big IVF markets

The best regional snapshot comes from REDLARA, the Latin American Network of Assisted Reproduction, which accredits more than 200 centers across the region — over 90% of the clinics that perform assisted reproduction in Latin America. At its 2026 congress, REDLARA’s figures placed Brazil first with about 40% of procedures, with Argentina and Mexico next at roughly 18% each. The average patient age across the network is about 38.

REDLARA accreditation matters for a traveling patient because it is an independent, regional quality signal: accredited centers report their outcomes and submit to peer standards. When you compare clinics in Mexico, “REDLARA-accredited” is one of the first filters worth applying.

Demand is growing from both sides of the border

Two trends are expanding Mexico’s fertility sector at once.

Domestic demand. Mexico’s total fertility rate has fallen from 6.8 children per woman in the 1960s to 1.9 in 2023 — below replacement — and women’s average age at first marriage rose from 27.6 in 2014 to 32.1 in 2024. Later family formation means more Mexican patients seeking IVF and egg freezing, which in turn supports more clinics, more embryologists and more competition on quality.

Cross-border demand. It is not only Mexico City and Cancún. In Chihuahua, a fertility institute that opened in 2024 reported 42% annual growth in treatment cycles and said patients come not just from neighboring Mexican states but from Texas, New Mexico and Colorado. Infertility affects roughly one in six couples in Mexico, and only about 64% of women with infertility receive care — so local capacity is growing alongside international demand.

The legal landscape: regulated, but not yet codified in one law

This is the part most patients find confusing, so it helps to be precise.

• IVF, ICSI, egg and sperm donation and embryo freezing are legal and practiced openly in Mexico. Clinics and laboratories operate under the Ley General de Salud and are licensed and inspected by COFEPRIS, the federal health regulator.
• What Mexico does not yet have is a single, comprehensive federal statute dedicated to assisted reproduction. A reform passed a committee in the Chamber of Deputies in 2025 but has not been enacted, and in April 2026 Senator Juan Carlos Loera de la Rosa announced a new bill to “fill the legal gaps,” centered on reproductive autonomy, equal access and legal certainty.
• Surrogacy is the exception to “legal nationwide”: only a few states regulate it expressly, and in February 2026 the Supreme Court set binding procedural criteria for surrogacy cases precisely because of the absence of a federal law. If surrogacy is part of your plan, specialized legal counsel is not optional.

For most patients — couples or individuals doing IVF with their own gametes or with donor eggs or sperm — the practical picture is a regulated system with a clear licensing authority, and a legislative process that is moving toward more clarity, not less.

What this means if you are considering the trip

Mexico’s case as a fertility destination rests on three things the data supports: scale (a multi-billion-dollar medical tourism sector built to receive foreign patients), quality signals you can verify (REDLARA accreditation, COFEPRIS licensing), and a cost structure that lets patients afford the number of cycles many will actually need.

None of that replaces due diligence on a specific clinic — which is exactly what our next article covers. But it should answer the first question: yes, this is a serious place to do something this important.

If you want to see what a treatment trip looks like step by step, start with the patient journey, or read more about why patients choose Mexico.